{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:08:43Z","timestamp":1790291323018,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.beem.2023.101745","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T11:12:11Z","timestamp":1676113931000},"page":"101745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genotype-phenotype correlations in Graves\u2019 disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Miko\u0142aj","family":"Radziszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Ku\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Bednarczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.beem.2023.101745_bib1","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","article-title":"Management of graves thyroidal and extrathyroidal disease: an update","volume":"105","author":"Kahaly","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101745_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Prim"},{"issue":"16","key":"10.1016\/j.beem.2023.101745_bib3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib4","doi-asserted-by":"crossref","first-page":"R241","DOI":"10.1530\/EJE-14-0047","article-title":"Mechanisms in endocrinology: autoimmune thyroid disease: old and new players","volume":"170","author":"Effraimidis","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101745_bib5","first-page":"930","article-title":"Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101745_bib6","article-title":"Genetics and epigenetics of autoimmune thyroid diseases: translational implications","author":"Lee","year":"2022","journal-title":"Best Practice Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101745_bib7","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-20-0078","article-title":"Graves' disease: introducing new genetic and epigenetic contributors","volume":"66","author":"Razmara","year":"2021","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/cen.12060","article-title":"Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005","volume":"78","author":"Nystrom","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12020-017-1306-5","article-title":"Epidemiology, management and outcomes of Graves' disease-real life data","volume":"56","author":"Hussain","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.0.1300565","article-title":"Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study","volume":"130","author":"Lavard","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2009.03717.x","article-title":"Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland","volume":"72","author":"Williamson","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/cen.13099","article-title":"Graves' disease in children: long-term outcomes of medical therapy","volume":"85","author":"Rabon","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2023.101745_bib13","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","article-title":"Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment","volume":"93","author":"Kaguelidou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.2005.02279.x","article-title":"Lymphoid tyrosine phosphatase (PTPN22\/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset","volume":"62","author":"Skorka","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059349","article-title":"Association between age at diagnosis of Graves' disease and variants in genes involved in immune response","volume":"8","author":"Jurecka-Lubieniecka","year":"2013","journal-title":"PloS one"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib16","doi-asserted-by":"crossref","first-page":"E1387","DOI":"10.1210\/jc.2013-4358","article-title":"Genetic analysis in young-age-of-onset Graves' disease reveals new susceptibility loci","volume":"99","author":"Brown","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101745_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/cge.13072","article-title":"Genetic study of early-onset Graves' disease in the Chinese Han population","volume":"93","author":"Yuan","year":"2018","journal-title":"Clin Gen"},{"issue":"2","key":"10.1016\/j.beem.2023.101745_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cen.13887","article-title":"Paediatric-onset and adult-onset Graves' disease share multiple genetic risk factors","volume":"90","author":"Kus","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2023.101745_bib19","doi-asserted-by":"crossref","first-page":"e3277","DOI":"10.1210\/clinem\/dgaa347","article-title":"An intronic HCP5 variant is associated with age of onset and susceptibility to Graves disease in UK and Polish Cohorts","volume":"105","author":"Lane","year":"2020","journal-title":"J Clinl Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2023.101745_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111991","article-title":"A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene","volume":"9","author":"Ciccacci","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2023.101745_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7682827","article-title":"STAT4, TRAF3IP2, IL10, and HCP5 polymorphisms in Sjogren's syndrome: association with disease susceptibility and clinical aspects","volume":"2019","author":"Colafrancesco","year":"2019","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001338","article-title":"A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci","volume":"4","author":"Liu","year":"2008","journal-title":"PLoS Gen"},{"issue":"9","key":"10.1016\/j.beem.2023.101745_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.autrev.2015.05.004","article-title":"Emerging role of long noncoding RNAs in autoimmune diseases","volume":"14","author":"Wu","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MED.0000000000000088","article-title":"Relapse following antithyroid drug therapy for Graves' hyperthyroidism","volume":"21","author":"Laurberg","year":"2014","journal-title":"Current Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2023.101745_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fendo.2017.00258","article-title":"Predictive value of gene polymorphisms on recurrence after the withdrawal of antithyroid drugs in patients with Graves' disease","volume":"8","author":"Liu","year":"2017","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib28","first-page":"2398","article-title":"The development of Graves' disease and the CTLA-4 gene on chromosome 2q33","volume":"84","author":"Heward","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12020-006-0017-0","article-title":"The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal","volume":"30","author":"Tanrikulu","year":"2006","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0029-1220902","article-title":"The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease","volume":"41","author":"Glowacka","year":"2009","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.beem.2023.101745_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12020-016-1096-1","article-title":"CD28\/CTLA-4\/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease","volume":"55","author":"Pawlak-Adamska","year":"2017","journal-title":"Endocrine"},{"issue":"12","key":"10.1016\/j.beem.2023.101745_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2007.0011","article-title":"Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease","volume":"17","author":"Kim","year":"2007","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1210\/jc.2015-3644","article-title":"Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with Graves' hyperthyroidism","volume":"101","author":"Vos","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib34","first-page":"689","article-title":"Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease","volume":"120","author":"Schleusener","year":"1989","journal-title":"Acta Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2023.101745_bib35","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40618-018-0918-9","article-title":"Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management","volume":"41","author":"Masiello","year":"2018","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11154-016-9386-8","article-title":"Relapse prediction in Graves disease: towards mathematical modeling of clinical, immune and genetic markers","volume":"17","author":"Langenstein","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib37","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1210\/endrev\/bnaa022","article-title":"New therapeutic horizons for Graves' hyperthyroidism","volume":"41","author":"Lane","year":"2020","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/thy.2019.0036","article-title":"Antigen-specific immunotherapy with thyrotropin receptor peptides in Graves' hyperthyroidism: a phase I study","volume":"29","author":"Pearce","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2023.101745_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.691781","article-title":"Precision medicine in Graves' disease: CD40 gene variants predict clinical response to an anti-CD40 monoclonal antibody","volume":"12","author":"Faustino","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/thy.2017.0301","article-title":"Alterations of global DNA methylation and DNA methyltransferase expression in T and B lymphocytes from patients with newly diagnosed autoimmune thyroid diseases after treatment: a follow-up study","volume":"28","author":"Guo","year":"2018","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.beem.2023.101745_bib41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2249.2012.04646.x","article-title":"Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease","volume":"170","author":"Arakawa","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12020-015-0546-5","article-title":"MiR-346 regulates CD4(+)CXCR5(+) T cells in the pathogenesis of Graves' disease","volume":"49","author":"Chen","year":"2015","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves' disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib44","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib45","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0189","article-title":"Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association","volume":"11","author":"Burch","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-18-0039","article-title":"Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism","volume":"178","author":"Wiersinga","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2023.101745_bib47","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1089\/thy.2022.0280","article-title":"Predictive model for Graves' ophthalmopathy in patients with new-onset Graves' disease","volume":"32","author":"Ahn","year":"2022","journal-title":"Thyroid."},{"issue":"1","key":"10.1016\/j.beem.2023.101745_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","article-title":"Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?","volume":"67","author":"Bednarczuk","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2023.101745_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41435-023-00193-z","article-title":"Significance of HLA in the development of Graves' orbitopathy","author":"Stasiak","year":"2023","journal-title":"Genes Immun"},{"key":"10.1016\/j.beem.2023.101745_bib50","article-title":"Associations of CTLA4 gene polymorphisms with Graves' ophthalmopathy: a meta-analysis","volume":"2014","author":"Du","year":"2014","journal-title":"Int J Genom"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102653","article-title":"Association between polymorphisms in the TSHR gene and Graves' orbitopathy","volume":"9","author":"Jurecka-Lubieniecka","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40618-014-0228-9","article-title":"TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy","volume":"38","author":"Bufalo","year":"2015","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/cen.12640","article-title":"The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' disease","volume":"83","author":"Kus","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1089\/thy.2012.0007","article-title":"Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy","volume":"22","author":"Yin","year":"2012","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beem.2011.10.004","article-title":"Ethnic differences in the clinical presentation of Graves' ophthalmopathy","volume":"26","author":"Chng","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jhg.2016.135","article-title":"Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy","volume":"62","author":"Kus","year":"2017","journal-title":"J Hum Genet"},{"issue":"10","key":"10.1016\/j.beem.2023.101745_bib57","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.ophtha.2014.04.027","article-title":"Single nucleotide polymorphisms at the PRR3, ABCF1, and GNL1 genes in the HLA class I region are associated with Graves' ophthalmopathy in a gender-dependent manner","volume":"121","author":"Liu","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.beem.2023.101745_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib59","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1167\/iovs.15-18797","article-title":"Association of polymorphisms in MACRO domain containing 2 with thyroid-associated orbitopathy","volume":"57","author":"Khong","year":"2016","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib60","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s12020-021-02952-2","article-title":"Increased risk of Graves ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres","volume":"75","author":"Shahida","year":"2022","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib61","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40618-017-0796-6","article-title":"A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy","volume":"41","author":"Xin","year":"2018","journal-title":"J Endocrinol Investig"},{"issue":"11","key":"10.1016\/j.beem.2023.101745_bib62","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1507\/endocrj.EJ14-0246","article-title":"Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy","volume":"61","author":"Wei","year":"2014","journal-title":"Endocr J"},{"issue":"10","key":"10.1016\/j.beem.2023.101745_bib63","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1167\/iovs.16-19213","article-title":"Role of miR-146a in the regulation of inflammation in an in vitro model of Graves' orbitopathy","volume":"57","author":"Jang","year":"2016","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"2","key":"10.1016\/j.beem.2023.101745_bib64","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12020-014-0487-4","article-title":"Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves' ophthalmopathy","volume":"49","author":"Shen","year":"2015","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.beem.2023.101745_bib65","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000331134","article-title":"Association of HLA alleles with autoimmune thyroid disease in Korean children","volume":"76","author":"Cho","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-0039.2012.01920.x","article-title":"The HLA-DRB1 gene and Graves disease in Taiwanese children: a case-control and family-based study","volume":"80","author":"Wu","year":"2012","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154394","article-title":"Association of cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene polymorphisms with autoimmune thyroid disease in children and adults: case-control study","volume":"11","author":"Ting","year":"2016","journal-title":"PloS one"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib69","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/JPEM.2008.21.7.665","article-title":"Association of CT60 polymorphism of the CTLA4 gene with Graves' disease in Taiwanese children","volume":"21","author":"Tsai","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib70","doi-asserted-by":"crossref","first-page":"641","DOI":"10.18388\/abp.2013_2034","article-title":"CTLA-4 polymorphisms (+49 A\/G and -318C\/T) are important genetic determinants of AITD susceptibility and predisposition to high levels of thyroid autoantibodies in Polish children - preliminary study","volume":"60","author":"Pastuszak-Lewandoska","year":"2013","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08916934.2018.1486824","article-title":"Analysis of chosen polymorphisms rs2476601 a\/G - PTPN22, rs1990760C\/T - IFIH1, rs179247 a\/G - TSHR in pathogenesis of autoimmune thyroid diseases in children","volume":"51","author":"Rydzewska","year":"2018","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib72","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/08916934.2014.910767","article-title":"Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases","volume":"47","author":"Bossowski","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.beem.2023.101745_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2304218","article-title":"Association of polymorphisms in toll-like receptors 4 and 9 with autoimmune thyroid disease in Korean pediatric patients","volume":"2017","author":"Cho","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2023.101745_bib74","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/105072503322401023","article-title":"Polymorphism in the transmembrane region of the major histocompatibility complex class I chain-related gene A: association of five GCT repetitions with Graves' disease in children","volume":"13","author":"Lo","year":"2003","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.beem.2023.101745_bib75","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/jc.2007-0675","article-title":"Association between a C\/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese","volume":"92","author":"Hsiao","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib76","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2006-2761","article-title":"Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study","volume":"92","author":"Wang","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2023.101745_bib77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000342621","article-title":"Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal","volume":"1","author":"Wang","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib78","first-page":"2593","article-title":"Remission of Graves' hyperthyroidism and A\/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene","volume":"87","author":"Kinjo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101745_bib79","first-page":"195","article-title":"The role of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene, thyroid stimulating hormone receptor (TSHR) gene and regulatory T-cells as risk factors for relapse in patients with Graves disease","volume":"49","author":"Eliana","year":"2017","journal-title":"Acta Med Indones"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib80","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejim.2005.06.007","article-title":"Cytotoxic T lymphocyte-associated molecule-4 polymorphisms in Turkish Graves' disease patients and association with probability of remission after antithyroid therapy","volume":"16","author":"Sahin","year":"2005","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.beem.2023.101745_bib81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12020-018-1785-z","article-title":"Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value","volume":"63","author":"Garcia-Mayor","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101745_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.761077","article-title":"Recurrence of Graves' disease: what genetics of HLA and PTPN22 can tell us","volume":"12","author":"Vejrazkova","year":"2021","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib83","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1365-2265.2003.01778.x","article-title":"CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism","volume":"58","author":"Vaidya","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humimm.2004.02.033","article-title":"Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy","volume":"65","author":"Bednarczuk","year":"2004","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib85","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2265.2000.01011.x","article-title":"A polymorphism of the 5\u2032 flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese","volume":"52","author":"Kamizono","year":"2000","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib86","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/eye.2009.244","article-title":"Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes","volume":"24","author":"Anvari","year":"2010","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.beem.2023.101745_bib87","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1442-9071.2009.02093.x","article-title":"Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist","volume":"37","author":"Khalilzadeh","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib88","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2265.2007.02942.x","article-title":"Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy","volume":"67","author":"Syed","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2023.101745_bib89","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2003-030131","article-title":"Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease","volume":"88","author":"Kretowski","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2023.101745_bib90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00251-013-0702-0","article-title":"PPARg2 Ala(1)(2) variant protects against Graves' orbitopathy and modulates the course of the disease","volume":"65","author":"Pawlak-Adamska","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.beem.2023.101745_bib91","article-title":"Polymorphisms of ATG5 gene are associated with autoimmune thyroid diseases, especially thyroid eye disease","volume":"2022","author":"Wang","year":"2022","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.beem.2023.101745_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216941","article-title":"HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease","volume":"14","author":"Shin","year":"2019","journal-title":"PloS One"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:57Z","timestamp":1761497997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521690X23000143"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101745","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-phenotype correlations in Graves\u2019 disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101745"}}